Ocriplasmin for symptomatic vitreomacular adhesion
Author:
Affiliation:
1. King's College Hospital; Department of Ophthalmology; Normanby Building Denmark Hill London UK SE5 9RS
2. King's College London; School of Medicine; London UK
Publisher
Wiley
Subject
Pharmacology (medical)
Reference69 articles.
1. Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial);Stalmans;Retina,2010
2. Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial;Dugel;Ophthalmology,2016
3. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials;Haller;Ophthalmology,2015
4. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes;Stalmans;New England Journal of Medicine,2012
5. Improvement in patient-reported visual function after ocriplasmin for vitreomacular adhesion: results of the microplasmin for intravitreous injection-traction release without surgical treatment (MIVI-TRUST) trials;Varma;JAMA Ophthalmology,2015
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies;Advanced Drug Delivery Reviews;2023-06
2. Identification of the Potential Molecular Mechanism of TGFBI Gene in Persistent Atrial Fibrillation;Computational and Mathematical Methods in Medicine;2022-11-08
3. Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine;Cells;2022-08-15
4. Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-02-05
5. Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis;Frontiers in Medicine;2022-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3